C/EBPd Gene Targets in Human Keratinocytes

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Borrelli, Serena ^a   Fanoni, Daniele ^a   Dolfini, Diletta ^a   Alotto, Daniela ^b   Ravo, Maria ^c   Grober, Olì Maria Victoria ^c   Weisz, Alessandro ^c,d   Castagnoli, Carlotta ^b   Berti, Emilio ^a,e   Vigano, M Alessandra ^a   Mantovani, Roberto ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CTO HOSPITAL   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^e UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; CELL MARKER; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR SOX2; MAFB PROTEIN, HUMAN; SOX2 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; BASAL CELL CARCINOMA; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; KERATINOCYTE; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; CELL CULTURE; CYTOLOGY; DNA MICROARRAY; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN; SKIN TUMOR; TISSUE MICROARRAY; WESTERN BLOTTING;

BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MAFB TRANSCRIPTION FACTOR; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN; SKIN NEOPLASMS; SOXB1 TRANSCRIPTION FACTORS; TISSUE ARRAY ANALYSIS;

EID: 78249253047     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013789     Document Type: Article

References (89)

1. Dai X, Segre JA (2004) Transcriptional control of epidermal specification and differentiation. Curr Opin Genet Dev 14: 485-491.
2. Ramji DP, Foka P (2002) CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J 2002, 365: 561-75.
3. Wang ND, Finegold MJ, Bradley A, Ou CN, Abdelsayed SV, et al. (1995) Impaired energy homeostasis in C/EBPalpha knockout mice. Science 269: 1108-12.
4. Sterneck E, Tessarollo L, Johnson PF (1997) An essential role for C/EBPbeta in female reproduction. Genes Dev 11: 2153-62.
5. Screpanti I, Romani L, Musiani P, Modesti A, Fattori E, et al. (1995) Lymphoproliferative disorder and imbalanced T-helper response in C/EBPbetadeficient mice. EMBO J 14: 1932-41.
6. Tanaka T, Yoshida N, Kishimoto T, Akira S (1997) Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J 16: 7432-7443.
7. Yamanaka R, Barlow C, Lekstrom-Himes J, Castilla LH, Liu PP, et al. (1997) Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/ enhancer binding protein epsilon-deficient mice. Proc Natl Acad Sci USA 94: 13187-13192.
8. Oyadomari S, Mori M (2004) Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11: 381-9.
9. Gigliotti AP, Johnson PF, Sterneck E, DeWille JW (2003) Nulliparous CCAAT/ enhancer binding protein delta (C/EBP delta) knockout mice exhibit mammary gland ductal hyperplasia. Exp Biol Med 228: 278-285.
10. Thangaraju M, Rudelius M, Bierie B, Raffeld M, Sharan S, et al. (2005) C/ EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development 132: 4675-4685.
11. Maytin EV, Habener JF (1998) Transcription factors C/EBPalpha, C/EBPbeta, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 110: 238-246.
12. Loomis KD, Zhu S, Yoon K, Johnson PF, Smart RC (2007) Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis. Cancer Res 67: 6768-76.
13. Zhu S, Oh HS, Shim M, Sterneck E, Johnson PF, et al. (1999) C/EBPb modulates the early events of keratinocyte differentiation involving growth arrest and keratin 1 and keratin 10 expression. Mol Cell Biol 19: 7181-7190.
14. Zhu S, Yoon K, Sterneck E, Johnson PF, Smart RC (2002) CCAAT/enhancer binding protein-β is a mediator of keratinocyte survival and skin tumorigenesis involving oncogenic ras signalling. Proc Natl Acad Sci USA 99: 207-212.
15. Sterneck E, Zhu S, Ramirez A, Jorcano JL, Smart RC (2006) Conditional ablation of C/EBPbeta demonstrates its keratinocyte-specific requirement for cell survival and mouse skin tumorigenesis. Oncogene 25: 1272-6.
16. Yoon K, Zhu S, Ewing SJ, Smart RC (2007) Decreased survival of C/EBPbetadeficient keratinocytes is due to aberrant regulation of p53 levels and function. Oncogene 26: 360-7.
17. Ewing SJ, Zhu S, Zhu F, House JS, Smart RC (2008) C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf). Cell Death Differ 15: 1734-44.
18. Lopez RG, Garcia-Silva S, Moore SJ, Bereshchenko O, Martinez-Cruz AB, et al. (2009) C/EBP alpha and beta couple interfollicular keratinocyte proliferation arrest to commitment and terminal differentiation. Nat Cell Biol 11: 1181-90.
19. Oh WJ, Rishi V, Orosz A, Gerdes MJ, Vinson C (2007) Inhibition of CCAAT/ Enhancer Binding Protein Family DNA Binding in Mouse Epidermis Prevents and Regresses Papillomas. Cancer Res 67: 1867-76.
20. Sterneck E, Paylor R, Jackson-Lewis V, Libbey M, Przedborski S, et al. (1998) Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc Natl Acad Sci USA 95: 10908-13.
21. Borrelli S, Testoni B, Callari M, Alotto D, Castagnoli C, et al. (2007) Reciprocal regulation of p63 by C/EBP delta in human keratinocytes. BMC Mol Biol 2007; 8: 85.
22. Barbaro V, Testa A, Di Iorio E, Mavilio F, Pellegrini G, et al. (2007) C/ EBPdelta regulates cell cycle and self-renewal of human limbal stem cells. J Cell Biol 177: 1037-1049.
23. Tada Y, Brena RM, Hackanson B, Morrison C, Otterson GA, et al. (2006) Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. J Natl Cancer Inst 98: 396-406.
24. Grimm SL, Rosen JM (2003) The role of C/EBP beta in mammary gland development and breast cancer. J Mammary Gland Biol Neoplasia 8: 191-204.
25. Sivko GS, DeWille JW (2004) CCAAT/Enhancer binding protein delta (c/ EBPdelta) regulation and expression in human mammary epithelial cells: I. ''Loss of function'' alterations in the c/EBP delta growth inhibitory pathway in breast cancer cell lines. J Cell Biochem 93: 830-843.
26. Tang D, Sivko GS, DeWille JW (2006) CCAAT/Enhancer binding protein delta (c/EBP delta) regulation and expression in human mammary epithelial cells: ''Loss of function'' alterations in the C/EBP delta growth inhibitory pathway in breast cancer cell lines. Breast Cancer Res Treat 95: 161-170.
27. Oh H-S, Smart RC (1998) Expression of CCAAT/enhancer binding protein (C/EBP) is associated with squamous differentiation in epidermis and isolated primary keratinocytes and is altered in skin neoplasms. J Invest Dermatol 110: 939-45.
28. Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, et al. (2008) PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 22: 2941-52.
29. Zhang Y, Liu T, Yan P, Huang T, Dewille J (2008) Identification and characterization of CCAAT/Enhancer Binding protein delta (C/EBPdelta) target genes in G0 growth arrested mammary epithelial cells. BMC Mol Biol 9: 83.
30. Testa A, Donati G, Yan P, Romani F, Huang TH, et al. (2005) Chromatin immunoprecipitation (ChIP) on chip experiments uncover a widespread distribution of NF-Y binding CCAAT sites outside of core promoters. J Biol Chem 280: 13606-15.
31. Viganò MA, Lamartine J, Testoni B, Merico D, Alotto D, et al. (2006) New p63 targets in keratinocytes identified by a genome-wide approach. EMBO J 25: 5105-5116.
32. Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA (2006) p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev 20: 3185-97.
33. Loots GG, Ovcharenko I, Pachter L, Dubchak I, Rubin EM (2002) rVista for comparative sequence-based discovery of functional transcription factor binding sites. Genome Res 12: 832-839.
34. Sandelin A, Wasserman WW, Lenhard B (2004) ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Res 32: 249-52.
35. Pozzi S, Zambelli F, Merico D, Pavesi G, Gidrol X, et al. (2009) Transcriptional network of p63 in human keratinocytes. PLoS ONE 4: e5008.
36. Testoni B, Borrelli S, Tenedini E, Alotto D, Castagnoli C, et al. (2006) Identification of a p63 regulatory network in keratinocytes. Cell Cycle 5: 2805-11.
37. Barbieri CE, Tang LJ, Brown KA, Pietenpol JA (2006) Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res 66: 7589-7597.
38. Carroll DK, Carroll JS, Leong CO, Cheng F, Brown M, et al. (2006) p63 regulates an adhesion programme and cell survival in epithelial cells. Nature Cell Biol 8: 551-561.
39. Della Gatta G, Bansal M, Ambesi-Impiombato A, Antonini D, Missero C, et al. (2008) Direct targets of the TRP63 transcription factor revealed by a combination of gene expression profiling and reverse engineering. Genome Res 18: 939-948.
40. Patel M, Yang S (2010) Advances in reprogramming somatic cells to induced pluripotent stem cells. Stem Cell Rev 6: 367-80.
41. Eychène A, Rocques N, Pouponnot C (2008) A new MAFia in cancer. Nat Rev Cancer 8: 683-93.
42. Deyoung MP, Ellisen LW (2007) p63 and p73 in human cancer: defining the network. Oncogene 26: 5169-83.
43. Smith C, Zhu K, Merritt A, Picton R, Youngs D, et al. (2004) Regulation of desmocollin gene expression in the epidermis: CCAAT/enhancer-binding proteins modulate early and late events in keratinocyte differentiation. Biochem J 380: 757-765.
44. Bull JJ, Muller-Rover S, Chronnell CM, Paus R, Philpott MP, et al. (2002) Contrasting expression patterns of CCAAT/enhancer-binding protein transcription factors in the hair follicle and at different stages of the hair growth cycle. J Invest Dermatol 118: 17-24.
45. Koizumi H, Kartasova T, Tanaka H, Ohkawara A, Kuroki T (1996) Differentiation-associated localization of small proline-rich protein in normal and diseased human skin. Br J Dermatol 134: 686-692.
46. Martin N, Patel S, Segre JA (2004) Long-range comparison of human and mouse Sprr loci to identify conserved noncoding sequences involved in coordinate regulation. Genome Res 14: 2430-2438.
47. Leong J, Hughes-Fulford M, Rakhlin N, Habib A, Maclouf J, et al. (1996) Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res 224: 79-87.
48. Neufang G, Furstenberger G, Heidt M, Marks F, Muller-Decker K (2001) Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin. Proc Natl Acad Sci USA 98: 7629-7634.
49. Eckert RL, Sturniolo MT, Jans R, Kraft CA, Jiang H, et al. (2009) TIG3: a regulator of type I transglutaminase activity in epidermis. Amino Acids 36: 739-46.
50. Ness SL, Edelmann W, Jenkins TD, Liedtke W, Rustgi AK, et al. (1998) Mouse keratin 4 is necessary for internal epithelial integrity. J Biol Chem 273: 23904-11.
51. Mägert HJ, Kreutzmann P, Drögemüller K, Ständker L, Adermann K, et al. (2002) The 15-domain serine proteinase inhibitor LEKTI: biochemical properties, genomic organization, and pathophysiological role. Eur J Med Res 7: 49-56.
52. Yang T, Liang D, Koch PJ, Hohl D, Kheradmand F, et al. (2004) Epidermal detachment, desmosomal dissociation, and destabilization of corneodesmosin in Spink5-/- mice. Genes Dev 18: 2354-2358.
53. Hewett DR, Simons AL, Mangan NE, Jolin HE, Green SM, et al. (2005) Lethal, neonatal ichthyosis with increased proteolytic processing of filaggrin in a mouse model of Netherton syndrome. Hum Mol Genet 14: 335-346.
54. Descargues P, Deraison C, Bonnart C, Kreft M, Kishibe M, et al. (2005) Spink5- deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 37: 56-65.
55. Komatsu N, Takata M, Otsuki N, Toyama T, Ohka R, et al. (2003) Expression and localization of tissue kallikrein mRNAs in human epidermis and appendages. J Invest Dermatol 121: 542-549.
56. Gosselet FP, Magnaldo T, Culerrier RM, Sarasin A, Ehrhart JC (2007) BMP2 and BMP6 control p57(Kip2) expression and cell growth arrest/terminal differentiation in normal primary human epidermal keratinocytes. Cell Signal 19: 731-9.
57. Jackson B, Tilli CM, Hardman MJ, Avilion AA, MacLeod MC, et al. (2005) Late cornified envelope family in differentiating epithelia-response to calcium and ultraviolet irradiation. J Invest Dermatol 124: 1062-70.
58. Richardson RJ, Dixon J, Malhotra S, Hardman MJ, Knowles L, et al. (2006) Irf6 is a key determinant of the keratinocyte proliferation differentiation switch. Nat Genet 38: 1329-1334.
59. Ingraham CR, Kinoshita A, Kondo S, Yang B, Sajan S, et al. (2006) Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nat Genet 38: 1335-40.
60. Segre JA, Bauer C, Fuchs E (1999) Klf4 is a transcription factor required for establishing the barrier function of the skin. Nat Genet 22: 356-360.
61. De Guzman Strong C, Wertz PW, Wang C, Yang F, Meltzer PS, et al. (2006) Lipid defect underlies selective skin barrier impairment of an epidermal-specific deletion of Gata-3. J Cell Biol 175: 661-70.
62. Chikh A, Sayan E, Thibaut S, Lena AM, DiGiorgi S, et al. (2007) Expression of GATA-3 in epidermis and hair follicle: relationship to p63. Biochem Biophys Res Commun 361: 1-6.
63. Borrelli S, Candi E, Hu B, Dolfini D, Ravo M, et al. (2010) The p63 target HBP-1 is important for keratinocyte differentiation and stratification. Cell Death and Differentiation, in press.
64. Cordani N, Pozzi S, Martynova E, Fanoni D, Borrelli S, et al. (2010) Mutant p53 subverts p63 control over KLF4 expression in keratinocytes. Oncogene, in press.
65. Sebastian T, Johnson PF (2006) Stop and go: anti-proliferative and mitogenic functions of the transcription factor C/EBPbeta. Cell Cycle 5: 953-957.
66. O'Rourke J, Yuan R, DeWille J (1999) CCAAT/enhancer-binding protein-delta (C/EBP-delta) is induced in growth-arrested mouse mammary epithelial cells. J Biol Chem 272: 6291-6296.
67. Sanford DC, DeWille JW (2005) C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells. Prostate 63: 143-54.
68. Hutt JA, O'Rourke JP, DeWille J (2000) Signal transducer and activator of transcription 3 activates CCAAT enhancer-binding protein delta gene transcription in G0 growth-arrested mouse mammary epithelial cells and in involuting mouse mammary gland. J Biol Chem 275: 29123-29131.
69. Hutt JA, DeWille JW (2002) Oncostatin M induces growth arrest of mammary epithelium via a CCAAT/enhancer-binding protein delta-dependent pathway. Mol Cancer Ther 1: 601-610.
70. Ikezoe T, Gery S, Yin D, O'Kelly J, Binderup L, et al. (2005) CCAAT/ enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells. Cancer Res 65: 4762-4768.
71. Ruchaud S, Carmena M, Earnshaw WC (2007) Chromosomal passengers: conducting cell division. Nat Rev Mol Cell Biol 798-812.
72. Famulski JK, Chan GK (2007) Aurora B kinase-dependent recruitment of hZW10 and hROD to tensionless kinetochores. Curr Biol 17: 2143-9.
73. Verlinden L, Eelen G, Beullens I, Van Camp M, Van Hummelen P, et al. (2005) Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3. J Biol Chem 280: 37319-30.
74. Huang AM, Montagna C, Sharan S, Ni Y, Ried T, et al. (2004) Loss of CCAAT/enhancer binding protein delta promotes chromosomal instability. Oncogene 23: 1549-1557.
75. Vogler R, Sauer B, Kim DS, Schäfer-Korting M, Kleuser B (2003) Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. J Invest Dermatol 120: 693-700.
76. Nishio H, Matsui K, Tsuji H, Tamura A, Suzuki K (2001) Immunolocalisation of the janus kinases (JAK)-signal transducers and activators of transcription (STAT) pathway in human epidermis. J Anat 198: 581-9.
77. Pusapati RV, Weaks RL, Rounbehler RJ, McArthur MJ, Johnson DG (2010) E2F2 suppresses Myc-induced proliferation and tumorigenesis. Mol Carcinog 49: 152-6.
78. van der Fits L, van der Wel LI, Laman JD, Prens EP, Verschuren MC (2003) Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2). J Pathol 199: 107-14.
79. Romeo G, Fiorucci G, Chiantore MV, Percario ZA, Vannucchi S, et al. (2002) IRF-1 as a negative regulator of cell proliferation. J Interferon Cytokine Res 22: 39-47.
80. Wenzel J, Tomiuk S, Zahn S, Küsters D, Vahsen A, et al. (2008) Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin. Int J Cancer 123: 2605-15.
81. Tsubooka N, Ichisaka T, Okita K, Takahashi K, Nakagawa M, et al. (2009) Roles of Sall4 in the generation of pluripotent stem cells from blastocysts and fibroblasts. Genes Cells 14: 683-94.
82. Yang J, Chai L, Gao C, Fowles TC, Alipio Z, et al. (2008) SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood 112: 805-13.
83. Fan Z, Yamaza T, Lee JS, Yu J, Wang S, et al. (2009) BCOR regulates mesenchymal stem cell function by epigenetic mechanisms. Nat Cell Biol 11: 1002-9.
84. Ogata A, Shimizu T, Abe R, Shimizu H, Sakai M (2004) Expression of c-maf and mafB genes in the skin during rat embryonic development. Acta Histochem 106: 65-7.
85. Motohashi H, Katsuoka F, Engel JD, Yamamoto M (2004) Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1- Nrf2 regulatory pathway. Proc Natl Acad Sci USA 101: 6379-84.
86. Pabst T, Mueller BU (2009) Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clin Cancer Res 15: 5303-7.
87. Raghunath M, Unsöld C, Kubitscheck U, Bruckner-Tuderman L, Peters R, et al. (1998) The cutaneous microfibrillar apparatus contains latent transforming growth factor-beta binding protein-1 (LTBP-1) and is a repository for latent TGF-beta1. J Invest Dermatol 111: 559-64.
88. Kömüves LG, Michael E, Arbeit JM, Ma XK, Kwong A, et al. (2002) HOXB4 homeodomain protein is expressed in developing epidermis and skin disorders and modulates keratinocyte proliferation. Dev Dyn 224: 58-68.
89. Tong Y, Eigler T (2009) Transcriptional targets for pituitary tumor-transforming gene-1. J Mol Endocrinol 43: 179-85.